Consistently, in clear cell renal cell carcinoma, lncRNA DMDRMR bound IGF2BP3 to stabilize CDK4 and three extracellular matrix components (COL6A1, LAMA5, and FN1) by specifically enhancing IGF2BP3 activity in a m6A-dependent manner [18]. This evidence concerns the gene IGF2BP3 and clear cell renal carcinoma.